Eli Lilly’s oncology arm, Loxo@Lilly, disclosed that The New England Journal of Medicine (NEJM) has published an extensive analysis of results from the BRUIN Phase 1/2 trials on pirtobrutinib, a reversible Bruton’s tyrosine kinase (BTK) inhibitor. Pirtobrutinib is being investigated for use in adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who […]
Marker Therapeutics said that the US Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for MT-601 for the treatment of relapsed/refractory (r/r) non-Hodgkin lymphoma (NHL). The IND is for the multi-tumor-associated antigen (multiTAA)-specific T cell product to be used in relapsed/refractory non-Hodgkin lymphoma patients who either failed or are not […]
Roche has secured approval from the US Food and Drug Administration (FDA) for its cobas EZH2 Mutation Test as a companion diagnostic for TAZVERIK (tazemetostat), developed by Epizyme. According to the Swiss healthare company, the molecular test can detect abnormalities in the EZH2, or Enhancer of Zeste Homolog 2, gene in patients having follicular lymphoma […]
Biological Name : Catharanthus roseus Family : Apocyanaceae Synonyms of Catharanthus: Hindi – Sadabahar Oriya – Ainskati Bengali – Nayantara Malayalam – Ushamalari Marathi – Sada-phul Tamil – Sudukadu mallikal Telugu – Billaganneru Catharanthus is an erect herb with a height of one metre. Flowers are white or purple-red in colour. It is grown throughout […]